An Open-label DDI Study of Omaveloxolone in Healthy Subjects

NCT05909644 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Subjects

Interventions

DRUG: Omaveloxolone
DRUG: Efavirenz

Sponsor

Biogen

Collaborators

[object Object]
[object Object]
[object Object]